• The Latest Updated Products
  • Home > Product Partnering > The Latest Updated Products
Basic Search Search

Displaying 1 of 2 results per page Prev Next

The Latest Updated Products 게시물 리스트
product_code originator Lab Code or BRAND NAME API Action mechanism Indication Latest development stage Details
 PP090703006498   RegeneRx Biopharmaceuticals, Inc.   RGN-259   timbetasin   Activating..   Neurotroph..   Phase III completed, Phase III    View Details 
 PP150721013324   Pfizer Inc.   Lisraya, PF-06700841, PF-841   brepocitinib tosylate   A selectiv..   Dermatomyo..   Approved, Phase III, Phase II, Phase II, Phase II, Phase II, Dropped, Phase III, Phase III    View Details 
 PP170223015633   Janssen Pharmaceuticals, Inc., a J&J (since Aug 2020), Momenta Pharmaceuticals   Imaavy, M281, JNJ-80202135   nipocalimab-aahu   An anti-Fc..   Generalize..   Approved, Approved, Phase II completed, Phase II, Phase II, Phase II, Phase III    View Details 
 PP171013016173   NicOx S.A.   NCX 470, K-911   bimatoprost grenod   A novel ni..   Glaucoma   NDA    View Details 
 PP181024016777   Protagonist Therapeutics Inc.   Mimrylo, PTG-300, TAK-121   rusfertide   A hepcidin..   Polycythem..   Approved, Phase II    View Details 
 PP230213020360   Astellas Pharma Inc.   ASP2138      An anti-CL..   Gastric ca..   Phase III, Phase I    View Details 
 PP240415021786   Gilead Sciences, Inc.   Bixlenvo   lenacapavir and bictegravir   A capsid i..   Human immu..   Approved    View Details 
 PP240716022185   Revolution Medicines, Inc.   Rasonque, RMC-6236, RAS-IN-2   compound A122; daraxonrasib   A potent R..   Pancreatic..   Approved, Phase II    View Details 
 PP240911022370   Relay Therapeutics, Inc.   RLY-4008   lirafugratinib   A selectiv..   Cholangioc..   NDA, Phase II    View Details 
 PP260828024428   Abbott Laboratories   Libre Duo 10 Day system         Glucose-ke..   Approved    View Details